the drug , currently known as atx-101 , now only needs to receive final fda approval before it becomes available to the public .
the drug , currently known as atx-101 , now only needs to receive final fda approval before it becomes available to the public .
unlike current double chin surgeries , which require doctors to ` cut it out or suck it out , ' atx-101 will be a ` noninvasive , in-the-office procedure , ' according to dr. susan weinkle .